Literature DB >> 10908567

Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization.

R M Lyu1, P M Germano, J K Choi, S V Le, J R Pisegna.   

Abstract

The pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 (PAC1) receptor is a G protein-coupled receptor and class II receptor member. The receptor domains critical for signaling are unknown. To explore the role of the C terminus, truncations of 63 residues (Tr406), 53 residues (Tr416), 49 residues (Tr420), 44 residues (Tr424), and 37 residues (Tr433) were constructed and expressed in NIH/3T3 cells, and immunofluorescence, radioligand binding, adenylyl cyclase (AC) and phospholipase C (PLC) assays were performed. (125)I-PACAP-27 binding (K(d) = 0.6-1.5 nm) for the Tr406 and Tr433 were similar to wild type Hop and Null splice variants (K(d) = approximately 1.1 nm). Although internalization of ligand for both the Tr406 and Tr433 mutants was reduced to 50-60% at 60 min compared with 76-87% for WT, loss of G protein coupling did not account for differences in internalization. Despite similar binding properties Tr406 and Tr416 mutants showed no AC or PLC response. Addition of 14 amino acids distal to HopTr406 resulted in normal AC and PLC responses. Site-directed mutagenesis indicated that Arg(416) and Ser(417) are essential for G protein activation. The proximal C terminus mediates signal transduction, and the distal is involved with internalization. Two residues within the C terminus, Arg(416) and Ser(417) conserved among class II receptors are the likely sites for G protein coupling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908567      PMCID: PMC6707528          DOI: 10.1074/jbc.M004612200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules.

Authors:  P J Lu; X Z Zhou; M Shen; K P Lu
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function.

Authors:  S Cotecchia; S Exum; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.

Authors:  A H Cheung; I S Sigal; R A Dixon; C D Strader
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

5.  The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation.

Authors:  A K Thompson; S P Mostafapour; L C Denlinger; J E Bleasdale; S K Fisher
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

6.  Three cytoplasmic loops of rhodopsin interact with transducin.

Authors:  B König; A Arendt; J H McDowell; M Kahlert; P A Hargrave; K P Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis.

Authors:  G D Chazenbalk; Y Nagayama; D Russo; H L Wadsworth; B Rapoport
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

8.  Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.

Authors:  A Varrault; L Journot; Y Audigier; J Bockaert
Journal:  Mol Pharmacol       Date:  1992-06       Impact factor: 4.436

9.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

Authors:  A Miyata; A Arimura; R R Dahl; N Minamino; A Uehara; L Jiang; M D Culler; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

10.  Yeast pheromone receptor endocytosis and hyperphosphorylation are independent of G protein-mediated signal transduction.

Authors:  B Zanolari; S Raths; B Singer-Krüger; H Riezman
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

View more
  12 in total

1.  (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist.

Authors:  Terry W Moody; Robert T Jensen; Mati Fridkin; Illana Gozes
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

2.  Homeodomain protein otp and activity-dependent splicing modulate neuronal adaptation to stress.

Authors:  Liat Amir-Zilberstein; Janna Blechman; Yehezkel Sztainberg; William H J Norton; Adriana Reuveny; Nataliya Borodovsky; Maayan Tahor; Joshua L Bonkowsky; Laure Bally-Cuif; Alon Chen; Gil Levkowitz
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 3.  PACAP-Induced PAC1 Receptor Internalization and Recruitment of Endosomal Signaling Regulate Cardiac Neuron Excitability.

Authors:  Rodney L Parsons; Victor May
Journal:  J Mol Neurosci       Date:  2018-07-27       Impact factor: 3.444

Review 4.  Peptide receptors as cancer drug targets.

Authors:  Terry W Moody
Journal:  Ann N Y Acad Sci       Date:  2019-05-10       Impact factor: 5.691

5.  Pituitary adenylate cyclase-activating polypeptide receptor activation in the hypothalamus recruits unique signaling pathways involved in energy homeostasis.

Authors:  Brian Maunze; Katherine Wood Bruckner; Nikhil Nilesh Desai; Christopher Chen; Fanghong Chen; David Baker; SuJean Choi
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-01-10       Impact factor: 4.310

6.  Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cells.

Authors:  D Reglodi; R Borzsei; T Bagoly; A Boronkai; B Racz; A Tamas; P Kiss; G Horvath; R Brubel; J Nemeth; G Toth; Z Helyes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

7.  Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation.

Authors:  Patrizia M Germano; Sang V Le; David S Oh; Robert Fan; Sandy Lieu; Alan Siu; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons.

Authors:  Marcel Miampamba; Patrizia M Germano; Selin Arli; Helen H Wong; David Scott; Yvette Taché; Joseph R Pisegna
Journal:  Regul Pept       Date:  2002-05-30

9.  PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells.

Authors:  Sang V Le; Dean J Yamaguchi; Craig A McArdle; Ken Tachiki; Joseph R Pisegna; Patrizia Germano
Journal:  Regul Pept       Date:  2002-11-15

10.  PACAP induces signaling and stimulation of 5-hydroxytryptamine release and growth in neuroendocrine tumor cells.

Authors:  Patrizia M Germano; Sandy N Lieu; Janjing Xue; Helen J Cooke; Fievos L Christofi; Yuxin Lu; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2009-08-23       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.